#DIYAPS use in the UK – A Snapshot
In the UK, at least 82 people (as of the date of publishing) are using DIY APS systems to manage their diabetes. Of these, the majority are using AndroidAPS.
In the UK, at least 82 people (as of the date of publishing) are using DIY APS systems to manage their diabetes. Of these, the majority are using AndroidAPS.
Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]
Over the past eight months, Nemaura have announced a number of outcomes of their clinical trials, all of which have suggested that after a tricky […]
If you’re a person with Type 1 Diabetes, it’s very hard not to have seen the news about Sir Michael Rawlins’ (Chair of the UK […]
If you keep your eyes on Diabetes and medical media, you can’t fail to have noticed that Roche’s Solo Micropump, a new patch pump from […]
Back at the end of March, when Dexcom launched the G6, I questioned how this might affect those using WeAreNotWaiting open source Diabetes technology. It […]
After six months of leaving Fiasp on the shelf, and occasionally using it as an adjunct injection when fast carbs were consumed (where it still […]
***Updated following clarification from the UK Distributor*** Whilst I recently tested and reported back on the Medtrum A6 CGM system, it’s not the only newcomer […]
With two sensors now used and a month of data captured, I felt it was time for further feedback on the newest CGM system on […]
After the initial couple of days with the Medtrum, and the data that was produced, I thought it would be a good idea to provide […]
Copyright © 2024 | WordPress Theme by MH Themes